Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Analytical Method Development: SOP for Residual Solvent Detection in Granules – V 2.0

Posted on By

Analytical Method Development: SOP for Residual Solvent Detection in Granules – V 2.0

Standard Operating Procedure for Residual Solvent Detection in Granules in Analytical Method Development


Department Analytical Method Development
SOP No. SOP/AMD/290/2025
Supersedes SOP/AMD/290/2022
Page No. Page 1 of 11
Issue Date 21/05/2025
Effective Date 23/05/2025
Review Date 21/05/2026

1. Purpose

To establish a validated and regulatory-compliant procedure for the qualitative and quantitative determination of residual solvents in pharmaceutical granules using Gas Chromatography (GC), as per ICH

Q3C guidelines.

2. Scope

This SOP is applicable to the Analytical Method Development and Quality Control departments responsible for testing residual solvents in granules produced during pharmaceutical formulation development and manufacturing.

3. Responsibilities

  • Analytical Scientist: Develops and validates GC methods for targeted solvents.
  • QC Analyst: Executes routine testing and records results.
  • QA Executive: Reviews and verifies data compliance and documentation accuracy.

4. Accountability

The Head of Analytical Method Development is accountable for ensuring validated detection and quantification of residual solvents in granules, ensuring adherence to ICH limits.

See also  Analytical Method Development: Reagent Qualification for Method Development - V 2.0

5. Procedure

5.1 Selection of Residual Solvents

  • Identify Class 1 (toxic), Class 2 (limited use), and Class 3 (low toxicity) solvents based on manufacturing process.
  • Target solvents must be listed as per ICH Q3C or internal specifications.

5.2 Sample Preparation

  1. Weigh approximately 500 mg of granules into a headspace vial.
  2. Add 5 mL of diluent (e.g., N,N-Dimethylformamide, water, or DMSO depending on solubility).
  3. Seal vial and allow equilibrium in the headspace autosampler (e.g., 80°C for 30 minutes).

5.3 Standard Preparation

  1. Prepare individual stock solutions of each target solvent in the same diluent.
  2. Prepare mixed working standard solutions covering ICH limits (e.g., 50%, 100%, 150%).

5.4 Gas Chromatography Conditions

  • Column: Fused silica capillary column (e.g., DB-624, 30 m × 0.32 mm × 1.8 µm)
  • Detector: Flame Ionization Detector (FID)
  • Carrier Gas: Helium or Nitrogen
  • Injection Mode: Headspace autosampler
  • Oven Program: 40°C (5 min), ramp to 220°C at 10°C/min, hold for 5 min
See also  Analytical Method Development: SOP for Preparation of Linearity Data Table - V 2.0

5.5 Method Validation

  1. Specificity: No interference from granule matrix or other excipients.
  2. Linearity: r² ≥ 0.995 across 50%–150% of ICH limits.
  3. LOD/LOQ: Determine by signal-to-noise ratio of 3:1 and 10:1 respectively.
  4. Accuracy: Recovery of 95%–105% for spiked solvents.
  5. Precision: RSD ≤ 5% for 6 replicates.

5.6 Acceptance Criteria

  • Each residual solvent must be below ICH-permitted daily exposure (PDE) limits:
  • Class 1: Not Detected or NMT specified ppm (e.g., Benzene NMT 2 ppm)
  • Class 2: NMT limits as per ICH Table 2 (e.g., Methanol NMT 3000 ppm)
  • Class 3: NMT 5000 ppm (unless otherwise specified)

6. Abbreviations

  • GC: Gas Chromatography
  • FID: Flame Ionization Detector
  • PDE: Permitted Daily Exposure
  • LOD: Limit of Detection
  • LOQ: Limit of Quantification

7. Documents

  1. GC Chromatogram and Area Report – Annexure-1
  2. Residual Solvent Quantification Sheet – Annexure-2
  3. Validation Summary Report – Annexure-3

8. References

  • ICH Q3C (R8): Impurities – Guidelines for Residual Solvents
  • USP <467>: Residual Solvents
  • Ph. Eur. 2.4.24: Identification and Control of Residual Solvents

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name Mehul Kapoor Sapna Joshi Sunita Reddy
Designation GC Analyst QA Reviewer Head – AMD
Department Analytical Method Development QA Analytical Method Development

11. Annexures

Annexure-1: GC Chromatogram and Area Report

Includes peaks for Class 1, 2, and 3 solvents. Retention time, peak area, and calculated concentration provided.

Annexure-2: Residual Solvent Quantification Sheet

Solvent RT (min) Amount (ppm) Limit (ppm) Status
Methanol 2.45 850 3000 Pass
Benzene 5.20 ND 2 Pass

Annexure-3: Validation Summary Report

The GC method for residual solvent detection in granules was validated as per ICH Q3C and USP <467>. The method demonstrated adequate specificity, sensitivity, and accuracy for regulatory use.

Revision History:

Revision Date Revision No. Details Reason Approved By
21/05/2025 2.0 Updated GC oven program and included full validation criteria Annual Review Sunita Reddy
15/10/2022 1.0 Initial SOP Release New SOP QA Head
See also  Analytical Method Development: Carryover Study SOP in HPLC - V 2.0
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: System Configuration Not Aligned with SOP Instructions: A Hidden IT Compliance Risk
Next Post: No Follow-Up to Verify SOP Effectiveness: A Common but Overlooked GMP Risk

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version